NCT03081819View on ClinicalTrials.gov

A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

April 16, 2019

Study Completion Date

July 25, 2019

Conditions
Solid Tumor, Adult
Interventions
DRUG

SH003

Herbal medicine for cancer treatment

Trial Locations (1)

16499

Ajou University Hospital, Suwon

All Listed Sponsors
lead

Kyunghee University Medical Center

OTHER

NCT03081819 - A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer | Biotech Hunter | Biotech Hunter